Boston's resTORbio Sets Terms for $85M IPO Post author:Sam Post published:January 16, 2018 Post category:BioPharma resTORbio is developing novel therapies to improve immune function in the elderly. Source: BioSpace You Might Also Like PPD???s Recognized For Industry Leadership August 10, 2017 Why Teva's Stock Could Crash Another 50% November 7, 2017 GOP Congressman Lost $16.7 Million in Single Day on This Tanking Biotech Stock June 27, 2017
